Separated Components
The research blend and liquid component remain in separate chambers before the device's dispensing process.
Cellular Response Research
KLOW Stack Pen — 80 mg
80 mg / pen
KLOW Stack Pen is an 80 mg pen-format laboratory product containing BPC-157, TB-500, GHK-Cu and KPV. Each component has its own research background.
Sale 11% off
€140,00€125,00
Research only
Secure checkout
Document available
For in-vitro laboratory research only. Not for human or veterinary use.This information is provided for scientific and educational product context only. It does not describe or recommend human use, veterinary use, diagnosis, treatment, prevention, dosage, administration, or clinical application.
Dual-Chamber Design
The KLOW Stack Pen is described as a dual-chamber device that keeps the research blend and its accompanying liquid component separated within the pen until the device's dispensing process.
Dispensing Context
The separated format is maintained until dispensing. No exact metering, chamber ratio or internal mechanism is claimed here.
Storage Format
Keeping the components separated reduces the time the research blend remains continuously prepared in solution and preserves the separated storage format.
Research-use product format. This section does not provide dosage or administration instructions.
At a glance
What It Does in the Body
Tissue Recovery
BPC-157 and TB-500 are studied for signals involved when damaged tissue responds and rebuilds. Most evidence comes from laboratory and animal models.
Skin and Collagen
GHK-Cu is studied for collagen and other support material that gives skin and tissues structure.
Digestive and Immune Signals
KPV is studied for chemical messages involved in inflammation and the protective lining of the intestines.
Blood Flow
BPC-157 and GHK-Cu research includes signals involved in forming small blood vessels.
Document available
Product document
Analytical documentation
Open the document and check that its product and batch details match your item.
This document applies only to the product and batch printed on it.
Full research details
Full research details for KLOW Stack Pen — 80 mg
Read the supporting laboratory, animal and human research. This section does not provide instructions for human or veterinary use, diagnosis, treatment, prevention, dosage or administration.
What this compound is
KLOW Stack Pen is listed as an 80 mg multi-compound laboratory reference blend. Its research profile follows the current KLOW Blend profile of BPC-157, TB-500, GHK-Cu and KPV.
MaterialMulti-compound reference blend
Main research areaIdentity-led cellular and matrix research
Evidence availableComponent-level laboratory research context
Catalogue categoryCellular Response Research
How It Works
Normal target and function. KLOW is an 80 mg multi-compound reference blend. BPC-157 research follows vascular and barrier signals; GHK-Cu binds copper; KPV research follows peptide transport and inflammatory signals. The existing batch notes also identify TB-500 as a named component.
The research profile presents each named component separately. BPC-157 sources focus on cell, blood-vessel and barrier models. GHK-Cu research concerns copper binding and the support structure around cells. KPV studies examine peptide transport and inflammatory messages. The batch documentation identifies TB-500 alongside the other components.
BPC-157 component
Linked sources describe preclinical cell, vascular and barrier-response models.
TB-500 component
The batch documentation identifies TB-500 as one of the named components.
GHK-Cu component
Component research examines copper binding and extracellular-matrix markers in controlled models.
KPV component
Component studies focus on epithelial transport and inflammatory signals in preclinical systems.
Laboratory and Animal Research
Separate cell and animal studies report model-specific findings for BPC-157, GHK-Cu and KPV under different experimental conditions.
Measurements used in these studies
- Whether the analytical document matches the product and identified batch
- Identity and amount of each component stated on that record
- Assay responses compared with separate component controls
- Stability and repeatability under defined laboratory conditions
Research Evidence
Human evidence
No verified human study of the KLOW blend is linked. Evidence for an individual component cannot show what the four-component blend would do in a person.
Adverse effects
No reliable human adverse-effect profile exists for KLOW or for the named components used together.
| Evidence type | What was studied | How much evidence | What this means |
|---|---|---|---|
| Laboratory research | Individual component sources | Indirect for the blend | BPC-157, GHK-Cu and KPV have separate laboratory contexts. No combined KLOW result is established. |
| Animal research | Individual component models | Preclinical and indirect | Animal observations for one component cannot be transferred to the blend or to people. |
| Human research | KLOW-specific studies | Not established | No verified human evidence for this blend is linked, and no combined outcome is claimed. |
Research references
BPC-157 component research
PubMed, 2018
Preclinical vascular and tissue-model background; not a KLOW study.
GHK-Cu component researchPubMed, 2022
Copper and matrix-related background; not evidence for the blend.
KPV component researchPubMed, 2007
Cell transport and inflammatory-signalling work; not a KLOW-specific result.